A new serological test in which an NAU professor played a pivotal role in developing can not only help humanity prepare for and respond to the next pandemic, but it also can be pivotal in the search for viral triggers of diseases like diabetes and celiac disease.
Jason Ladner, an assistant professor… Read more
COVID-19 vaccination activates antibodies targeting parts of virus spike protein shared between coronaviruses
Could the SARS-CoV-2 vaccine reawaken previous antibody responses and point the way to a universal coronavirus vaccine? A new analysis of the antibody response to a COVID-19 vaccine suggests the immune system’s history with other coronaviruses, including those behind the common cold, shapes the patient’s response, according to a study published… Read more
NAU-TGen study results show COVID-19 virus triggers antibodies from previous coronavirus infections
The results of a study led by Northern Arizona University and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest the immune systems of people infected with COVID-19 may rely on antibodies created during infections from earlier coronaviruses to help fight the disease.
COVID-19 isn’t humanity’s first encounter with a coronavirus, so named because… Read more
NAU research team sees major shift in relationship between state-by-state traffic and COVID-19 cases, offering insights into outcomes of lockdown policies
The upper left panel shows that during the month of March 2020, the decline in traffic across the US coincided with the rise in COVID-19 cases. The country responded in a uniform fashion. The lower panel shows how that correlation in traffic-COVID-19 broke down with traffic rising in most states but COVID-19 cases rising in… Read moreNAU pathogen scientist collaborating on vaccine that could prevent and treat COVID-19
C. Todd French, assistant professor of biology and leader of Northern Arizona University’s new COVID-19 Testing Service Center (CTSC), is working with scientists at Vault Pharma, an emerging biotechnology company, to test candidate vaccines against the novel coronavirus. Through a multi-institutional public-private partnership linking the company with UCLA, NAU and the University of Nebraska–Lincoln, French is… Read more
Scientists collaborate across NAU’s research centers to create new physics-based technology for COVID-19 detection
One of the most challenging aspects of the COVID-19 pandemic has been the lack of testing needed to detect and trace infections—and without adequate testing, government officials do not have the data they need to make the best possible decisions in the interest of public health.
In addition to being in short supply,… Read more